Cargando…
Response to “COVID-19 in persons with haematological cancers”
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289538/ https://www.ncbi.nlm.nih.gov/pubmed/32528043 http://dx.doi.org/10.1038/s41375-020-0914-x |
| _version_ | 1783545483361255424 |
|---|---|
| author | Hatzl, Stefan Eisner, Florian Schilcher, Gernot Kreuzer, Philipp Gornicec, Maximilian Eller, Philipp Brodmann, Marianne Schlenke, Peter Stradner, Martin Helmut Krause, Robert Greinix, Hildegard Schulz, Eduard |
| author_facet | Hatzl, Stefan Eisner, Florian Schilcher, Gernot Kreuzer, Philipp Gornicec, Maximilian Eller, Philipp Brodmann, Marianne Schlenke, Peter Stradner, Martin Helmut Krause, Robert Greinix, Hildegard Schulz, Eduard |
| author_sort | Hatzl, Stefan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7289538 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72895382020-06-12 Response to “COVID-19 in persons with haematological cancers” Hatzl, Stefan Eisner, Florian Schilcher, Gernot Kreuzer, Philipp Gornicec, Maximilian Eller, Philipp Brodmann, Marianne Schlenke, Peter Stradner, Martin Helmut Krause, Robert Greinix, Hildegard Schulz, Eduard Leukemia Correspondence Nature Publishing Group UK 2020-06-11 2020 /pmc/articles/PMC7289538/ /pubmed/32528043 http://dx.doi.org/10.1038/s41375-020-0914-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Hatzl, Stefan Eisner, Florian Schilcher, Gernot Kreuzer, Philipp Gornicec, Maximilian Eller, Philipp Brodmann, Marianne Schlenke, Peter Stradner, Martin Helmut Krause, Robert Greinix, Hildegard Schulz, Eduard Response to “COVID-19 in persons with haematological cancers” |
| title | Response to “COVID-19 in persons with haematological cancers” |
| title_full | Response to “COVID-19 in persons with haematological cancers” |
| title_fullStr | Response to “COVID-19 in persons with haematological cancers” |
| title_full_unstemmed | Response to “COVID-19 in persons with haematological cancers” |
| title_short | Response to “COVID-19 in persons with haematological cancers” |
| title_sort | response to “covid-19 in persons with haematological cancers” |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289538/ https://www.ncbi.nlm.nih.gov/pubmed/32528043 http://dx.doi.org/10.1038/s41375-020-0914-x |
| work_keys_str_mv | AT hatzlstefan responsetocovid19inpersonswithhaematologicalcancers AT eisnerflorian responsetocovid19inpersonswithhaematologicalcancers AT schilchergernot responsetocovid19inpersonswithhaematologicalcancers AT kreuzerphilipp responsetocovid19inpersonswithhaematologicalcancers AT gornicecmaximilian responsetocovid19inpersonswithhaematologicalcancers AT ellerphilipp responsetocovid19inpersonswithhaematologicalcancers AT brodmannmarianne responsetocovid19inpersonswithhaematologicalcancers AT schlenkepeter responsetocovid19inpersonswithhaematologicalcancers AT stradnermartinhelmut responsetocovid19inpersonswithhaematologicalcancers AT krauserobert responsetocovid19inpersonswithhaematologicalcancers AT greinixhildegard responsetocovid19inpersonswithhaematologicalcancers AT schulzeduard responsetocovid19inpersonswithhaematologicalcancers |